Correlation Between Shanghai Rongtai and Jiangsu GDK

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Shanghai Rongtai and Jiangsu GDK at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Shanghai Rongtai and Jiangsu GDK into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Shanghai Rongtai Health and Jiangsu GDK Biotechnology, you can compare the effects of market volatilities on Shanghai Rongtai and Jiangsu GDK and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Shanghai Rongtai with a short position of Jiangsu GDK. Check out your portfolio center. Please also check ongoing floating volatility patterns of Shanghai Rongtai and Jiangsu GDK.

Diversification Opportunities for Shanghai Rongtai and Jiangsu GDK

0.87
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Shanghai and Jiangsu is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Shanghai Rongtai Health and Jiangsu GDK Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Jiangsu GDK Biotechnology and Shanghai Rongtai is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Shanghai Rongtai Health are associated (or correlated) with Jiangsu GDK. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Jiangsu GDK Biotechnology has no effect on the direction of Shanghai Rongtai i.e., Shanghai Rongtai and Jiangsu GDK go up and down completely randomly.

Pair Corralation between Shanghai Rongtai and Jiangsu GDK

Assuming the 90 days trading horizon Shanghai Rongtai Health is expected to under-perform the Jiangsu GDK. But the stock apears to be less risky and, when comparing its historical volatility, Shanghai Rongtai Health is 1.86 times less risky than Jiangsu GDK. The stock trades about -0.01 of its potential returns per unit of risk. The Jiangsu GDK Biotechnology is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  1,206  in Jiangsu GDK Biotechnology on September 25, 2024 and sell it today you would earn a total of  103.00  from holding Jiangsu GDK Biotechnology or generate 8.54% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Shanghai Rongtai Health  vs.  Jiangsu GDK Biotechnology

 Performance 
       Timeline  
Shanghai Rongtai Health 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Shanghai Rongtai Health are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Shanghai Rongtai sustained solid returns over the last few months and may actually be approaching a breakup point.
Jiangsu GDK Biotechnology 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Jiangsu GDK Biotechnology are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Jiangsu GDK sustained solid returns over the last few months and may actually be approaching a breakup point.

Shanghai Rongtai and Jiangsu GDK Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Shanghai Rongtai and Jiangsu GDK

The main advantage of trading using opposite Shanghai Rongtai and Jiangsu GDK positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Shanghai Rongtai position performs unexpectedly, Jiangsu GDK can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Jiangsu GDK will offset losses from the drop in Jiangsu GDK's long position.
The idea behind Shanghai Rongtai Health and Jiangsu GDK Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account